logo

Neurocrine Biosciences Inc (NBIX)



Trade NBIX now with
  Date
  Headline
11/22/2021 8:02:41 AM Neurocrine And Sosei To Develop Muscarinic Receptor Agonists For Schizophrenia And Other Neuropsychiatric Disorders
11/2/2021 8:21:30 AM William Blair Is Increasing Neurocrine Biosciences Inc (NBIX) FY23 Rev. Estimate To 2.05 Billion From 1.98 Billion
11/2/2021 8:21:15 AM William Blair Is Increasing Neurocrine Biosciences Inc (NBIX) FY22 Rev. Estimate To 1.46 Billion From 1.40 Billion
11/2/2021 8:21:03 AM William Blair Is Increasing Neurocrine Biosciences Inc (NBIX) FY21 Rev. Estimate To 1.17 Billion From 1.15 Billion
11/2/2021 8:19:58 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY23 Estimate To 7.62 From 8.46
11/2/2021 8:19:43 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY22 Estimate To 3.25 From 3.74
11/2/2021 8:19:32 AM William Blair Is Lowering Neurocrine Biosciences Inc (NBIX) FY21 Estimate To 2.66 From 2.90
11/2/2021 8:18:45 AM William Blair Reiterates Neurocrine Biosciences Inc (NBIX) At Outperform
11/1/2021 4:04:08 PM Neurocrine Biosciences Q3 EPS $0.23 Vs. Loss $0.62 Year Ago
11/1/2021 8:02:12 AM Neurocrine Biosciences Presents New INGREZZA Data At Psych Congress 2021
9/10/2021 9:26:15 AM Neurocrine Biosciences To Present New INGREZZA And ONGENTYS Data At MDS Virtual Congress 2021
8/3/2021 4:04:46 PM Neurocrine Biosciences Q2 EPS $0.43 Vs. $0.81 Year Ago